Skip to content
NEO·Nasdaq·US

NeoGenomics

NeoGenomics is a U.S.-based oncology diagnostics company that provides cancer testing services for physicians, hospitals, and pharmaceutical partners. Its offerings include laboratory-developed tests, clinical trial support, and related pathology and molecular diagnostics services.

Thematic Position

NEO

Relationship Groups

Suppliers1
Customers1
Partners1
Competitors7

Relationship details are part of the Pro plan.

Ended Relationships

3 ended relationships · Ended relationships are part of the Pro plan.

Management Perspective on Regulatory & Geopolitical Developments

federal healthcare lawfraud and abuse regulation
OIG investigation into federal healthcare law compliance constrains NeoGenomics operations
SEC 10-QApr 28, 2026

The full regulatory passage is part of the Pro plan.

13 more · Regulatory and geopolitical insights are part of the Pro plan.